Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between ABCG2 Polymorphism and Statin-Induced Adverse Events: A Meta-Analysis.

Cardiovascular toxicology - 1 Nov 2025

Lee Da Hoon, Shin Hae Ji, Yoon Beom, Kim Han Wool, Jo Hyeon Woo, Kim Hee Jung, Kim Woorim

Abstract excerpt

Statins, widely used for preventing cardiovascular diseases due to their cholesterol-lowering effects, are associated with potential adverse reactions in some individuals, underscoring the need to understand the factors contributing to statin-related complications. The ATP-binding cassette subfamily G member 2 (ABCG2) gene, which encodes a multidrug transporter, has garnered attention due to its involvement in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily G, Member 2
Share to Chemical and Drug Induced Liver Injury

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Muscular Diseases

Share to Neoplasm Proteins

Share to Pharmacogenomic Variants

Share to Risk Assessment

Source

Identifiers

PMID: 40848094
DOI: 10.1007/s12012-025-10056-w

Genes

ABCG2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association Between ABCG2 Polymorphism and Statin-Induced Adverse Events: A Meta-Analysis.PMID 40848094Read ↗

Liver and Statins: A Critical Appraisal of the Evidence.Semantic proximity Read ↗

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of StatinsSemantic proximity Read ↗

Transporter Genes and statin-induced Hepatotoxicity.Semantic proximity Read ↗

Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy.Semantic proximity Read ↗

[Statin-induced adverse effects -- facts and genes].Semantic proximity Read ↗

ABCG2 gene polymorphisms as risk factors for atorvastatin adverse reactions: a case-control study.Semantic proximity Read ↗

Pharmacogenetics of statins treatment: Efficacy and safetySemantic proximity Read ↗

The pharmacogenomics of statins.Semantic proximity Read ↗

Pharmacogenetics of Statin-Induced MyotoxicitySemantic proximity Read ↗

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping reviewSemantic proximity Read ↗

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins.Semantic proximity Read ↗

Clinical implications of pharmacogenetic variation on the effects of statins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.